Home » today » Business » Bertelsmann Investments Acquires Pharmaceutical Technology Company EXTEDO for Double-Digit Million Amount

Bertelsmann Investments Acquires Pharmaceutical Technology Company EXTEDO for Double-Digit Million Amount

Bertelsmann Investments is acquiring the pharmaceutical technology company EXTEDO for a double-digit million amount. A Taylor Wessing team led by the two partners Dr. Gregor Schmid (Berlin) and Dr. Niclas von Woedtke (Hamburg) advised Bertelsmann Investments on all legal issues related to the acquisition.

Bertelsmann Investments is the investment arm of Bertelsmann and has so far invested around 1.7 billion euros in over 400 innovative companies and funds. The investment company currently holds shares in more than 360 innovative companies and funds, particularly in the areas of education, digital media, fintech, e-commerce and adtech. The acquisition of EXTEDO expands the corporate portfolio of Bertelsmann Investments with the aim of strategically expanding the position in the European growth market of pharmaceutical technology in association and through synergies with existing investment companies. As a leading provider of software solutions and services in the area of ​​regulatory information, EXTEDO brings extensive expertise that both customers from industry and authorities rely on.

EXTEDO’s customers include around 1,000 pharmaceutical companies and public institutions in more than 65 countries, including, for example, 35 regulatory authorities, who use the pharmaceutical technology service provider’s solutions to optimize their regulatory business processes in the areas of document management, product registration, approval management and drug safety.

Legal advisor Bertelsmann Investments
Taylor Wessing Germany:
Joint leadership Dr. Gregor Schmid (Partner, IP / IT / Data Law, Berlin) and Dr. Niclas von Woedtke (Salary Partner, Corporate/M&A, Hamburg); Dr. Jens Wolf (Partner), Philipp Hoegl (Salary Partner), Philipp Bergjans (Associate), all M&A/Venture Capital, all Hamburg; Dr. Stefanie Greifeneder (partner), Dr. Andrea Sautter (salary partner), Sherin Sayed (associate), all Patents Technology & Life Sciences, all Munich; Nico Jänicke (Partner), Jan-Mathias Pfleging (Senior Associate), Alois Lobkowicz (Associate), all Employment, Pensions & Mobility, all Berlin; Thanos Rammos (Partner), Hazal Viola Koepp-Strand (Associate), both IT and data law, Dr. Eva Surowiecki, LL.B. (Associate, IP / IT / Data Law), all Berlin

Inhouse Bertelsmann Investments: Dr. Martin Dannhoff (leader)

Legal advisor for the seller: Dornbach RAe

2024-02-22 12:20:04
#Bertelsmann #Investments #acquiring #pharmaceutical #tech #company #EXTEDO #Taylor #Wessing

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.